The efficacy and safety of TNF inhibitor (golimumab) as salvage treatment in patients with refractory noninfectious uveitis.

Jin, Yi; Lu, Shanshan; Lin, You; Mou, Xiaoyue

Jin, Yi; Lu, Shanshan; Lin, You; Mou, Xiaoyue.

Afiliación

Jin Y; Department of Ophthalmology, First People's Hospital of Taizhou, Taizhou, China.
Lu S; Department of Ophthalmology, First People's Hospital of Taizhou, Taizhou, China.
Lin Y; Department of Ophthalmology, First People's Hospital of Taizhou, Taizhou, China.
Mou X; Department of Rheumatology, First People's Hospital of Taizhou, No. 218 Hengjie Road, Taizhou, 318020, China. yue83673907@163.com.

Inflammopharmacology ; 30(4): 1363-1368, 2022 Aug.

Article en En | MEDLINE | ID: mdl-35802282

Asunto(s)

Inhibidores del Factor de Necrosis Tumoral; Uveítis; Anticuerpos Monoclonales; Anticuerpos Monoclonales Humanizados; Humanos; Terapia Recuperativa; Resultado del Tratamiento; Uveítis/tratamiento farmacológico

Palabras clave

Efficacy; Golimumab; Refractory noninfectious uveitis; Safety; TNF inhibitor

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Uveítis / Inhibidores del Factor de Necrosis Tumoral Límite: Humans Idioma: En Revista: Inflammopharmacology Asunto de la revista: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Año: 2022 Tipo del documento: Article País de afiliación: China

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google